🇺🇸 Codeine + Diclofenac in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Anaemia — 1 report (12.5%)
2. Asthenia — 1 report (12.5%)
3. Bursitis — 1 report (12.5%)
4. Gastric Haemorrhage — 1 report (12.5%)
5. Peritonitis — 1 report (12.5%)
6. Platelet Count Decreased — 1 report (12.5%)
7. Rotator Cuff Syndrome — 1 report (12.5%)
8. Stevens-Johnson Syndrome — 1 report (12.5%)

Source database →

Frequently asked questions

Is Codeine + Diclofenac approved in United States?

Codeine + Diclofenac does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Codeine + Diclofenac in United States?

University of Sao Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.